Episode 536 - Uromigos Live 2026 – High-risk Localized Prostate Cancer
From The Uromigos · · 48 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Several phase 3 trials in high-risk localized prostate cancer have reported this year including PROTEUS and DASL. The panel debates if and how these will impact treatment of this patient population.